Janice R. Andrews
Walmart has announced the appointment of Dr. Cheryl Pegus as executive vice president of Health & Wellness, which is a big development. Renowned for her leadership in healthcare solutions, Dr. Pegus will oversee Walmart’s healthcare vision, which aims to improve wellness and health services throughout the organization.
With an extensive background in healthcare, Dr. Pegus assumes a leadership position directly under Walmart U.S. CEO John Furner. Her experience in clinical strategy, consumer health, and healthcare administration is demonstrated by her positions as chief medical officer and president of consumer health solutions at Cambia Health Solutions, in addition to her prior employment at Pfizer, Aetna, and Walgreens.
In addition to being a highly regarded medical expert, Dr. Pegus is a committed supporter of diversity and health fairness. As a board member of the American Heart Association and co-founder of A New Beat, she has supported programs aimed at enhancing cardiovascular health for women and underrepresented minorities.
Dr. Pegus will oversee Walmart’s all-inclusive healthcare strategy, utilizing the company’s extensive pharmacy network, Vision facilities, Walmart Health facilities, and digital health resources. Walmart wants to promote the well-being of communities around the country by transforming key healthcare services and emphasizing cost and accessibility.
In addition to expressing her excitement for her new position, Dr. Pegus stressed the need of cooperation and partnership in providing associates and communities with easily accessible and reasonably priced healthcare.
Walmart’s dedication to healthcare innovation is demonstrated by its innovative $4 generic medicine price initiative, which has drastically lowered healthcare costs for customers, quarterly wellness days, and millions of free health screenings.
Walmart’s goal to offer high-quality, reasonably priced healthcare solutions has advanced significantly with the appointment of Dr. Cheryl Pegus, especially in light of the persisting difficulties brought on by the epidemic.
